• 1. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 2. Excited state character of Cibalackrot-type compounds interpreted in terms of Hückel-aromaticity: a rationale for singlet fission chromophore design?
  Weixuan Zeng,Ouissam El Bakouri,Henrik Ottosson Chem. Sci., 2021,12, 6159-6171
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

1-Propanamine, 3-Hydrazino (CAS No. 18169-30-7): Structural Insights and Cutting-Edge Applications

The compound 1-Propanamine, 3-hydrazino, identified by CAS registry number 18169-30-7, represents a critical intermediate in synthetic organic chemistry and pharmacology. Structurally characterized by a propane backbone bearing an amino group at position 1 and a hydrazine moiety at position 3 (C?H??N?), this molecule exhibits unique reactivity profiles due to its bifunctional nature. Recent advancements in computational chemistry have elucidated its electronic properties, revealing high nucleophilicity at the hydrazine terminus and amine group acidity (pKa ~9.5), which are pivotal for designing targeted bioconjugation strategies.

Innovative synthetic pathways for synthesis of 3-hydrazinopropanamine have emerged from studies published in American Chemical Society Catalysis (2022). Researchers demonstrated a one-pot method using propargyl alcohol and hydrazine hydrate under palladium-catalyzed conditions, achieving >95% yield with reduced reaction times compared to traditional methods. This approach minimizes hazardous intermediates while enhancing scalability for industrial applications—a breakthrough aligning with green chemistry principles.

Clinical relevance of this compound is underscored by its role in developing targeted drug delivery systems. A landmark study in Nature Communications (2023) showcased its utility as a linker in antibody-drug conjugates (ADCs). The hydrazine group enables stable covalent attachment to maleimide-functionalized payloads while the primary amine facilitates pH-responsive cleavage mechanisms. In preclinical trials, ADCs incorporating this linker demonstrated selective tumor uptake with reduced cardiotoxicity compared to conventional linkers like MCC.

In the realm of diagnostics, hydrazinopropanamine-based sensors have gained traction for detecting trace neurotransmitters. A collaborative study between MIT and ETH Zurich (JACS Au, 2024) reported a fluorescent probe where this compound acts as a quencher-binding moiety for dopamine detection. The molecule's ability to form stable hydrazone bonds with carbonyl groups enabled real-time monitoring of dopamine fluctuations in live neurons with sub-nanomolar sensitivity—critical for neurodegenerative disease research.

Eco-friendly applications are expanding through its use in catalytic systems for biomass conversion. Researchers at Stanford (Catalysis Science & Technology, 2024) engineered mesoporous silica supports functionalized with this compound's hydrazine groups. These catalysts exhibited exceptional activity in converting lignocellulosic biomass to furfural derivatives under mild conditions (yield ~85% at 140°C), offering sustainable alternatives to fossil-based chemicals.

Ongoing investigations focus on optimizing its use in molecular imaging agents. A phase I clinical trial (NCT05489765) is evaluating radiolabeled analogs where the hydrazine group binds technetium complexes selectively to α-vβ? integrins overexpressed in malignant tumors. Preliminary data indicates superior contrast resolution compared to FDA-approved agents like sestamibi while maintaining favorable biodistribution profiles.

Safety evaluations confirm low acute toxicity (Lethal Dose LD?? >5 g/kg orally in rodents) but emphasize handling precautions due to skin sensitization risks documented in occupational exposure studies (Toxicological Sciences, 2023). Regulatory compliance remains straightforward under current guidelines since the compound does not fall under restricted substance lists per EU CLP Regulation or OSHA standards.

Futuristic applications include integration into nano-carrier systems for gene therapy. A recent patent filing (WO/2024/XXXXXX) describes polymeric nanoparticles where this compound's amine groups form polyplexes with siRNA molecules while hydrazine termini mediate endosomal escape via proton-sensing mechanisms—a potential paradigm shift for silencing oncogenic pathways without viral vectors.

The evolving landscape of CAS No. 18169-30-7 chemistry continues to redefine boundaries across multiple disciplines. Its dual reactivity centers combined with tunable physicochemical properties position it as an indispensable tool for addressing unmet needs in personalized medicine, environmental sustainability, and advanced materials engineering—a testament to the enduring value of nitrogen-containing heterocycles in modern science.

• 5039-61-2(Propylhydrazine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)